Drugs to Stop “Cold Turkey”: Tramadol

Tramadol is not a benign middle-ground analgesic; it is a weak opioid with serotonergic activity, seizure risk, and highly variable metabolism. In emergency medicine pain management, its benefits are modest while its adverse effects and overdose pitfalls are unusually broad.

Why Tramadol Falls Short

• Questionable analgesic efficacy: Head-to-head trials show tramadol often performs no better than acetaminophen for some acute pain syndromes and can underperform hydrocodone-acetaminophen in musculoskeletal pain.
• Weak opioid with extra baggage: Tramadol adds serotonin and norepinephrine reuptake effects to modest mu-opioid activity, creating a side-effect profile that is more complex than its analgesic payoff suggests.
• Unpredictable CYP2D6 metabolism: Its active metabolite depends on CYP2D6, so poor and ultrarapid metabolizers can see either disappointing pain control or outsized toxicity from the same prescribed dose.
• Not first choice in ED: For acute pain, acetaminophen and ibuprofen are preferred starts, and if an opioid is truly needed, a direct opioid is usually the cleaner choice. We get into the practical prescribing logic in the episode.

Major Safety Problems With Tramadol

• Seizure-provoking potential: Tramadol lowers the seizure threshold enough that one Australian ED study linked it to more than 8% of first-time seizure presentations, a memorable signal against casual use.
• Serotonergic toxicity risk: Because tramadol inhibits serotonin reuptake, combining it with antidepressants and other serotonergic drugs can precipitate serotonin syndrome rather than simply additive sedation.
• Hypoglycemia association: Tramadol has been associated with clinically important hypoglycemia, an adverse effect easy to miss when altered mental status or diaphoresis is attributed to pain or opioid exposure alone.
• Overdose reversal limitations: Tramadol overdose is not a straightforward naloxone story because toxicity can include seizures and non-opioid mechanisms, with management nuances we walk through in the episode.
• Dependence and withdrawal: Despite early safer-opioid marketing, tramadol can cause addiction and a mixed withdrawal syndrome with both opioid-like and atypical features after regular use.

References:

1. Schnitzer TJ, et al. Efficacy of tramadol in treatment of chronic low back pain. J Rheumatol. 2000;27(3):772-778. PMID: 10743823
2. Oguzturk H, et al. Tramadol or paracetamol do not effect the diagnostic accuracy of acute abdominal pain with significant pain relief - a prospective, randomized, placebo controlled double blind study. Eur Rev Med Pharmacol Sci. 2012 Dec;16(14):1983-8. PMID: 23242726
3. Turturro MA, et al. Tramadol versus hydrocodone-acetaminophen in acute musculoskeletal pain: a randomized, double-blind clinical trial. Ann Emerg Med. 1998 Aug;32(2):139-43. PMID: 9701294
4. Sachs CJ. Oral analgesics for acute nonspecific pain. Am Fam Physician. 2005;71:913-8. PMID: 15768621
5. Leppert W. CYP2D6 in the metabolism of opioids for mild to moderate pain. Pharmacology. 2011;87(5-6):274-85. PMID: 21494059
6. Labate A, et al. Tramadol and new-onset seizures. Med J Aust.2005;182:42-44.  PMID: 15651948
7. Fournier JP, Azoulay L, Yin H, et al. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. JAMA Intern Med. 2015 Feb;175(2):186-93. PMID: 25485799
8. Sansone RA, Sansone LA. Tramadol: seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont). 2009 Apr;6(4):17-21. PMID: 19724727 
9. Senay EC, et al. Physical dependence on Ultram® (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend 2003;69:233-4. PMID: 12633909
10. Spiller HA, et al. Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol. 1997;35:361-364. PMID: 9204095